| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |